title: Survivorship in adolescents and young adults.
abstract: In the USA, approximately 26,000 adolescents and young adults (AYAs) aged 15-29 years are diagnosed with cancer every year. The cure rate among this population exceeds 80%, resulting in a growing number of AYA cancer survivors. AYA cancer survivors suffer from a wide range of long-term treatment-related toxicities that adversely affect quality of life and increase the risk of premature death. Therefore, it is important to recognize the unique medical needs of the AYA cancer survivors and develop a cost-effective and systemic approach to screen and prevent cancer treatment-related sequelae and the adverse health outcomes.
authors.affiliation: Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, N.Y., USA.
authors.forename: Ashwin
authors.initials: A
authors.lastname: Kishtagari
authors.forename: Montreh
authors.initials: M
authors.lastname: Tavakkoli
authors.forename: Jae H
authors.initials: JH
authors.lastname: Park
mesh_terms: D003131:Combined Modality Therapy / Q000009:adverse effects*; D004702:Endocrine Glands / Q000503:physiopathology; D006331:Heart Diseases / Q000209:etiology / Q000401:mortality; D019337:Hematologic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008171:Lung Diseases / Q000209:etiology / Q000401:mortality; D009422:Nervous System Diseases / Q000209:etiology / Q000401:mortality; D015996:Survival Rate; D013964:Thyroid Neoplasms / Q000401:mortality / Q000556:secondary